Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 2,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Dysplasia Mild Clear all

Conditions: Mild Traumatic Brain Injury, Concussion, Post-concussive Syndrome
Interventions: Mandated Rest, Intervention; Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 11 Years to 22 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer, Hormone-Refractory Prostate Cancer
Interventions: GnRH agonist/antagonist, Prednisone, Abiraterone Acetate, Enzalutamide; Biological · Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2029
U.S. locations: 5
States / cities: Los Angeles, California • Chicago, Illinois • New Orleans, Louisiana + 2 more

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Centella asiatica product, Placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 60 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Mild Cognitive Impairment
Interventions: Patient Survey, Mini Cog, Independent Activities of Daily Living Score Sheet, Activities of Daily Living Score Sheet, Geriatric Depression Scale Short Form, Confusion Assessment Method (CAM), RAND 36-Item Short Form Health Survey, Grip Strength; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 65 Years and older
Enrollment: 711 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne Vulgaris
Interventions: Acne Mask; Device
Lead sponsor: Johnson & Johnson Consumer Inc. (J&JCI); Industry
Eligibility: 12 Years to 40 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Concussion, Brain, Mild Traumatic Brain Injury
Interventions: EyeBOX device; Diagnostic Test
Lead sponsor: Oculogica, Inc.; Industry
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Renal Impairment
Interventions: Topirmate and Phentermine; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 19 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 4
States / cities: Anaheim, California • Miami, Florida • Orlando, Florida + 1 more

Conditions: Alzheimer's Disease
Interventions: Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg; Drug
Lead sponsor: JANSSEN Alzheimer Immunotherapy Research & Development, LLC; Industry
Eligibility: 50 Years to 88 Years
Enrollment: 1,331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 219
States / cities: Birmingham, Alabama • Goodyear, Arizona • Phoenix, Arizona + 170 more

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: North Coast Medical Activadose II; Device
Lead sponsor: The Mind Research Network; Other
Eligibility: 50 Years to 90 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Hepatic Impairment
Interventions: Cotadutide; Combination Product
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Hialeah, Florida • San Antonio, Texas

Conditions: Hepatic Impairment
Interventions: JNJ-56021927; Drug
Lead sponsor: Aragon Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Knoxville, Tennessee • San Antonio, Texas

Conditions: Dementia, Mild, Mild Cognitive Impairment, Disability Physical, Impairment, Cognitive, Caregiver Burden, Quality of Life, Depression
Interventions: CAPABLE Family - Open Label Pilot, CAPABLE Family - Randomized Control Trial; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Foot Ulcer, Diabetic
Interventions: Topical Dermacyn, Topical Dermacyn and Levofloxacin, Topical Saline and Levofloxacin; Drug
Lead sponsor: Oculus Innovative Sciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 16
States / cities: Tucson, Arizona • La Jolla, California • Los Angeles, California + 13 more

Conditions: Alzheimer Disease, Down Syndrome, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Post-Traumatic Headache, PTSD, TBI, TBI (Traumatic Brain Injury), MTBI - Mild Traumatic Brain Injury, Posttraumatic Stress Disorder, Posttraumatic Stress Disorder, Delayed Onset, Sleep Disturbance, Nightmare, Nightmares, REM-Sleep Type, Headache, Irritable Mood, Anger, Eating Disorders, Combat and Operational Stress Reaction, Combat Stress Disorders, Military Operations, Military Activity, Military Family
Interventions: Art Therapy; Behavioral
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Asthma, Reactive Airway Disease
Interventions: Dexamethasone, Prednisone; Drug
Lead sponsor: Alameda County Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Oakland, California

Conditions: Alzheimer Disease (AD), Cardio Vascular Disease, Mild Cognitive Impairment (MCI), Frailty Syndrome, Disability Physical, Hypertension, Metabolic Syndrome (MetS), Healthy Aging, Obesity &Amp; Overweight
Interventions: Not listed
Lead sponsor: Marymount University; Other
Eligibility: 50 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Arlington, Virginia

Conditions: Concussion, Brain, Mild Traumatic Brain Injury
Interventions: SCAT6, Visual/ Auditory Distraction; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Mild Cognitive Impairment
Interventions: Aerobic & Cognitive Training (ACT), Cycling Only, Cognitive Training Only, Stretching and Mental Stimulating Activities; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 65 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 4
States / cities: Phoenix, Arizona • Stanford, California • Minneapolis, Minnesota + 1 more

Conditions: Acne
Interventions: Geologie Acne Regimen - one side of face, Proactive Acne Regimen - other side of face; Combination Product
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: ARDS (Acute Respiratory Distress Syndrome)
Interventions: HT31-1, Saline (0.9%, sterile, for infusion); Drug · Other
Lead sponsor: HTIC, Inc; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Asthma
Interventions: CREON2000A; Device
Lead sponsor: General Innovations and Goods, Inc.; Industry
Eligibility: 6 Years to 18 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 8
States / cities: Homestead, Florida • Lexington, Kentucky • Cincinnati, Ohio + 4 more

Conditions: Dehydration
Interventions: recombinant human hyaluronidase; Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 30 Days to 10 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 25
States / cities: Hartford, Connecticut • Orlando, Florida • Tampa, Florida + 20 more

Conditions: Depression, Multiple Sclerosis
Interventions: escitalopram oxalate antidepressant; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: White Plains, New York

Search by objective public record fields.

Effect of Early Rest on Recovery From Pediatric Concussion

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older

A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

EyeBOX Concussion Study and Registry

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease

Pharmacokinetics of Cotadutide in Participants With Hepatic Impairment

A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study

Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms

Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

The Effects of Environmental Distractions on SCAT6 Outcomes

The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial

Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS

Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma

Subcutaneous Rehydration Compared to Intravenous Rehydration

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis